Related Experiment Video
Updated: Feb 26, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Impairment of Coronary Endothelial Function by Hypoxia-Reoxygenation Involves TRPC3 Inhibition-mediated KCa Channel
Xiang-Chong Wang1, Wen-Tao Sun1, Jie Fu1
1Division of Cardiology, Department of Medicine and Therapeutics, Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Insights
Hypoxia-reoxygenation injury impairs coronary artery function by inhibiting calcium-activated potassium (KCa) channels, a process linked to TRPC3 channel dysfunction. Restoring TRPC3 activity improves vasodilation, suggesting it as a therapeutic target.
Area of Science:
- Endothelial physiology
- Cardiovascular research
- Ion channel function
Background:
- Calcium-activated potassium (KCa) and canonical transient receptor potential (TRPC) channels are crucial for endothelial function.
- Hypoxia-reoxygenation (H-R) previously shown to inhibit these channels in porcine coronary arteries (PCAs).
- The interplay between TRPC3 and KCa channels in pathological vascular tone remains unexplored.
Purpose of the Study:
- To investigate the role of TRPC3 channel modulation in H-R-induced KCa channel inhibition.
- To determine the contribution of TRPC3 to endothelial dysfunction and impaired vasodilation following H-R.
- To explore TRPC3 as a potential therapeutic target for ischemia-reperfusion (I-R) injury.
Main Methods:
- Wire myography to assess vascular tone.
- Whole-cell voltage-clamp electrophysiology on porcine coronary artery endothelial cells (PCAECs).
- Co-immunoprecipitation to examine protein interactions.
- Pharmacological inhibition and siRNA silencing of TRPC3.
- Bradykinin stimulation to assess channel activity.
Main Results:
- TRPC3 inhibition or silencing reduced bradykinin-induced intermediate- and small-conductance KCa (IKCa and SKCa) currents in PCAECs.
- TRPC3 protein did not physically associate with IKCa or SKCa channels.
- H-R exposure weakened the response of IKCa and SKCa to bradykinin and TRPC3 inhibition.
- TRPC3 channel activation reversed H-R-induced suppression of KCa currents and improved endothelium-derived hyperpolarizing factor (EDHF)-type vasorelaxation.
Conclusions:
- TRPC3 channel inhibition contributes to H-R-induced suppression of KCa channel activity.
- This mechanism underlies coronary endothelial dysfunction in ischemia-reperfusion (I-R) injury.
- TRPC3 represents a potential therapeutic target for endothelial protection in I-R conditions.
Abstract:
Despite increasing knowledge of the significance of calcium-activated potassium (KCa) and canonical transient receptor potential (TRPC) channels in endothelial physiology, no studies so far have investigated the link between these two distinct types of channels in the control of vascular tone in pathological conditions. We previously demonstrated that hypoxia-reoxygenation (H-R) inhibits endothelial KCa and TRPC3 channels in porcine coronary arteries (PCAs). The present study further investigated whether modulation of TRPC3 is involved in H-R-induced KCa channel inhibition and associated vasodilatory dysfunction using approaches of wire myography, whole-cell voltage-clamp, and coimmunoprecipitation. Pharmacological inhibition or siRNA silencing of TRPC3 significantly suppressed bradykinin-induced intermediate- and small-conductance KCa (IKCa and SKCa) currents in endothelial cells of PCAs (PCAECs). TRPC3 protein exists in physical association with neither IKCa nor SKCa. In H-R-exposed PCAECs, the response of IKCa and SKCa to bradykinin-stimulation and to TRPC3-inhibition was markedly weakened. Activation of TRPC3 channels restored H-R-suppressed KCa currents in association with an improved endothelium-derived hyperpolarizing factor (EDHF)-type vasorelaxation. We conclude that inhibition of TRPC3 channels contributes to H-R-induced suppression of KCa channel activity, which serves as a mechanism underlying coronary endothelial dysfunction in ischemia-reperfusion (I-R) injury and renders TRPC3 a potential target for endothelial protection in I-R conditions.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease I: Introduction

